277 related articles for article (PubMed ID: 25261325)
1. Iloprost reverses established fibrosis in experimental right ventricular failure.
Gomez-Arroyo J; Sakagami M; Syed AA; Farkas L; Van Tassell B; Kraskauskas D; Mizuno S; Abbate A; Bogaard HJ; Byron PR; Voelkel NF
Eur Respir J; 2015 Feb; 45(2):449-62. PubMed ID: 25261325
[TBL] [Abstract][Full Text] [Related]
2. Carvedilol improves biventricular fibrosis and function in experimental pulmonary hypertension.
Okumura K; Kato H; Honjo O; Breitling S; Kuebler WM; Sun M; Friedberg MK
J Mol Med (Berl); 2015 Jun; 93(6):663-74. PubMed ID: 25595602
[TBL] [Abstract][Full Text] [Related]
3. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
Schermuly RT; Kreisselmeier KP; Ghofrani HA; Samidurai A; Pullamsetti S; Weissmann N; Schudt C; Ermert L; Seeger W; Grimminger F
Circ Res; 2004 Apr; 94(8):1101-8. PubMed ID: 15031263
[TBL] [Abstract][Full Text] [Related]
4. Natural reversal of pulmonary vascular remodeling and right ventricular remodeling in SU5416/hypoxia-treated Sprague-Dawley rats.
Zungu-Edmondson M; Shults NV; Melnyk O; Suzuki YJ
PLoS One; 2017; 12(8):e0182551. PubMed ID: 28809956
[TBL] [Abstract][Full Text] [Related]
5. Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats.
Bogaard HJ; Natarajan R; Mizuno S; Abbate A; Chang PJ; Chau VQ; Hoke NN; Kraskauskas D; Kasper M; Salloum FN; Voelkel NF
Am J Respir Crit Care Med; 2010 Sep; 182(5):652-60. PubMed ID: 20508210
[TBL] [Abstract][Full Text] [Related]
6. Experimental Right Ventricular Hypertension Induces Regional β1-Integrin-Mediated Transduction of Hypertrophic and Profibrotic Right and Left Ventricular Signaling.
Sun M; Ishii R; Okumura K; Krauszman A; Breitling S; Gomez O; Hinek A; Boo S; Hinz B; Connelly KA; Kuebler WM; Friedberg MK
J Am Heart Assoc; 2018 Mar; 7(7):. PubMed ID: 29599211
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of mesenchymal stem cell delivery via a novel cardiac bioscaffold on right ventricles of pulmonary arterial hypertensive rats.
Schmuck EG; Hacker TA; Schreier DA; Chesler NC; Wang Z
Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1005-H1013. PubMed ID: 30822119
[TBL] [Abstract][Full Text] [Related]
8. Rutaecarpine attenuates hypoxia-induced right ventricular remodeling in rats.
Li WQ; Li XH; Du J; Zhang W; Li D; Xiong XM; Li YJ
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):757-67. PubMed ID: 27052575
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic Metabolic Reprogramming of Right Ventricular Fibroblasts in Pulmonary Arterial Hypertension: A Pyruvate Dehydrogenase Kinase-Dependent Shift in Mitochondrial Metabolism Promotes Right Ventricular Fibrosis.
Tian L; Wu D; Dasgupta A; Chen KH; Mewburn J; Potus F; Lima PDA; Hong Z; Zhao YY; Hindmarch CCT; Kutty S; Provencher S; Bonnet S; Sutendra G; Archer SL
Circ Res; 2020 Jun; 126(12):1723-1745. PubMed ID: 32216531
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of treprostinil in the SU5416-hypoxia model of severe pulmonary arterial hypertension: haemodynamic benefits are not associated with improvements in arterial remodelling.
Chaudhary KR; Deng Y; Suen CM; Taha M; Petersen TH; Mei SHJ; Stewart DJ
Br J Pharmacol; 2018 Oct; 175(20):3976-3989. PubMed ID: 30098019
[TBL] [Abstract][Full Text] [Related]
11. Rho kinase mediates right ventricular systolic dysfunction in rats with chronic neonatal pulmonary hypertension.
Gosal K; Dunlop K; Dhaliwal R; Ivanovska J; Kantores C; Desjardins JF; Connelly KA; McNamara PJ; Jain A; Jankov RP
Am J Respir Cell Mol Biol; 2015 Jun; 52(6):717-27. PubMed ID: 25337652
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological Inhibition of mTOR Kinase Reverses Right Ventricle Remodeling and Improves Right Ventricle Structure and Function in Rats.
Pena A; Kobir A; Goncharov D; Goda A; Kudryashova TV; Ray A; Vanderpool R; Baust J; Chang B; Mora AL; Gorcsan J; Goncharova EA
Am J Respir Cell Mol Biol; 2017 Nov; 57(5):615-625. PubMed ID: 28679058
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of combination therapy with inhaled nitric oxide and iloprost in patients with pulmonary hypertension and right ventricular dysfunction after high-risk cardiac surgery.
Antoniou T; Koletsis EN; Prokakis C; Rellia P; Thanopoulos A; Theodoraki K; Zarkalis D; Sfyrakis P
J Cardiothorac Vasc Anesth; 2013 Jun; 27(3):459-66. PubMed ID: 23063102
[TBL] [Abstract][Full Text] [Related]
14. Prostacyclin therapy increases right ventricular capillarisation in a model for flow-associated pulmonary hypertension.
van Albada ME; Berger RM; Niggebrugge M; van Veghel R; Cromme-Dijkhuis AH; Schoemaker RG
Eur J Pharmacol; 2006 Nov; 549(1-3):107-16. PubMed ID: 16978602
[TBL] [Abstract][Full Text] [Related]
15. Modulators of right ventricular apoptosis and contractility in a rat model of pulmonary hypertension.
Zungu-Edmondson M; Shults NV; Wong CM; Suzuki YJ
Cardiovasc Res; 2016 May; 110(1):30-9. PubMed ID: 26790474
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of right coronary vascular dysfunction in severe pulmonary hypertensive rats using synchrotron radiation microangiography.
Inagaki T; Pearson JT; Tsuchimochi H; Schwenke DO; Saito S; Higuchi T; Masaki T; Umetani K; Shirai M; Nakaoka Y
Am J Physiol Heart Circ Physiol; 2021 Mar; 320(3):H1021-H1036. PubMed ID: 33481696
[TBL] [Abstract][Full Text] [Related]
17. Dehydroepiandrosterone restores right ventricular structure and function in rats with severe pulmonary arterial hypertension.
Alzoubi A; Toba M; Abe K; O'Neill KD; Rocic P; Fagan KA; McMurtry IF; Oka M
Am J Physiol Heart Circ Physiol; 2013 Jun; 304(12):H1708-18. PubMed ID: 23585128
[TBL] [Abstract][Full Text] [Related]
18. The selective PGI2 receptor agonist selexipag ameliorates Sugen 5416/hypoxia-induced pulmonary arterial hypertension in rats.
Honda Y; Kosugi K; Fuchikami C; Kuramoto K; Numakura Y; Kuwano K
PLoS One; 2020; 15(10):e0240692. PubMed ID: 33057388
[TBL] [Abstract][Full Text] [Related]
19. Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertension.
Rol N; de Raaf MA; Sun XQ; Kuiper VP; da Silva Gonçalves Bos D; Happé C; Kurakula K; Dickhoff C; Thuillet R; Tu L; Guignabert C; Schalij I; Lodder K; Pan X; Herrmann FE; van Nieuw Amerongen GP; Koolwijk P; Vonk-Noordegraaf A; de Man FS; Wollin L; Goumans MJ; Szulcek R; Bogaard HJ
Cardiovasc Res; 2019 Feb; 115(2):432-439. PubMed ID: 30032282
[TBL] [Abstract][Full Text] [Related]
20. Salubrinal attenuates right ventricular hypertrophy and dysfunction in hypoxic pulmonary hypertension of rats.
He YY; Liu CL; Li X; Li RJ; Wang LL; He KL
Vascul Pharmacol; 2016 Dec; 87():190-198. PubMed ID: 27678416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
